Skip to content
Prostate and Genitourinary Cancer Research Pioneer
Paul Lange, M.D. selected Distinguished Member for 2015.
Dr. Lange is internationally recognized for his clinical and experimental work in a variety of genitourinary cancers, especially prostate and testis. Early on he was instrumental in the elucidation of the biological markers AFP and hCG for testis tumors and later for the role of PSA in the management of prostate cancer.
He is currently University of Washington Emeritus Professor and Chair in UW’s Department of Urology, holds the Pritt Family Endowed Chair in Prostate Cancer Research, and is Director of the Institute for Prostate Cancer Research – a cooperative collaboration between UW and the Fred Hutchinson Cancer Research Center.
Dr. Lange is internationally recognized for his clinical and experimental work in a variety of genitourinary cancers, especially prostate and testis. Early on he was instrumental in the elucidation of the biological markers AFP and hCG for testis tumors and later for the role of PSA in the management of prostate cancer.
He is currently University of Washington Emeritus Professor and Chair in UW’s Department of Urology, holds the Pritt Family Endowed Chair in Prostate Cancer Research, and is Director of the Institute for Prostate Cancer Research – a cooperative collaboration between UW and the Fred Hutchinson Cancer Research Center.
Please join us in honoring Dr. Lange during the Member’s Business Meeting on Wednesday, Oct. 28, 2015 in Indian Wells, CA.
Scroll To Top
Dr. Lange is internationally recognized for his clinical and experimental work in a variety of genitourinary cancers, especially prostate and testis. Early on he was instrumental in the elucidation of the biological markers AFP and hCG for testis tumors and later for the role of PSA in the management of prostate cancer.